BioLineRx Ltd. American Depositary Shares
BLRX
Closed
$3.03
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Key stats
Open
$2.83
Volume
10.80K
Market cap
$39.31M
Prev. close
$3.03
Impl / hst vl
-
Open interest
$0.00
$2.77
Day’s Range
$3.03
$2.15
52W Range
$3.95
Valuation
66
Valuation score
Undervalued
P/E
-
P/S
10.94
P/B
0.71
Current ratio
1.95
Debt / Equity
0.38
ROE
-10.27%
Gross margin
79.38%
Income growth
128.86%
FCF growth
53.23
Analysts estimates
Earnings
Q4 ‘25 revenue
$194.00K
Q4 ‘25 net income
-$2.24M
Revenue
Net income
Previous EPS
-Estimate EPS
$0.00
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply